University of Rhode Island

DigitalCommons@URI
Open Access Dissertations
2016

Prescription Stimulant Misuse: The Relationship Between
Executive Functioning and Academic Outcomes
Bailey Munro
University of Rhode Island, bailey_munro@my.uri.edu

Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss

Recommended Citation
Munro, Bailey, "Prescription Stimulant Misuse: The Relationship Between Executive Functioning and
Academic Outcomes" (2016). Open Access Dissertations. Paper 466.
https://digitalcommons.uri.edu/oa_diss/466

This Dissertation is brought to you for free and open access by DigitalCommons@URI. It has been accepted for
inclusion in Open Access Dissertations by an authorized administrator of DigitalCommons@URI. For more
information, please contact digitalcommons@etal.uri.edu.

PRESCRIPTION STIMULANT MISUSE: THE RELATIONSHIP BETWEEN
EXECUTIVE FUNCTIONING AND ACADEMIC OUTCOMES
BY
BAILEY MUNRO

A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
IN
INTERDISCIPLINARY NEUROSCIENCE

UNIVERSITY OF RHODE ISLAND
2016

DOCTOR OF PHILOSOPY DISSERTATION
OF
BAILEY MUNRO

APPROVED:
Dissertation Committee:
Major Professor

Lisa Weyandt
Grant Willis
Natallia Katenka
Nasser H. Zawia
DEAN OF THE GRADUATE SCHOOL

UNIVERSITY OF RHODE ISLAND
2016

ABSTRACT
Prescription stimulant misuse is a growing problem among college students.
Students found to be at greatest risk for misusing prescription stimulants are those
who are male, Caucasian, members of a fraternity or sorority, and who have a lower
grade point average (GPA). The primary reason reported for stimulant misuse among
college students is academic enhancement. Preliminary findings investigating
executive functioning (EF) in college students has revealed that individuals with
deficits in EF are more likely to have educational difficulties and take part in risky
behavior, and that executive functions are substantially improved in students with
attention-deficit/hyperactivity disorder and EF deficits when taking prescription
stimulants. It is possible that students who have greater difficulty with planning,
organization, self-motivation, and interference control (i.e., EF deficits) are misusing
prescription stimulants to help them overcome these deficits to succeed academically.
Therefore, the purpose of the present study was to examine the relationship between
prescription stimulant misuse, EF, and academic outcomes among a sample of college
students. Results revealed 18.8% of the sample reported misusing prescription
stimulants. In addition, participants with clinically significant EF deficits reported
significantly higher rates of misuse, compared to those without deficits in EF.
Prescription stimulant misuse, however, did not moderate the relationship between EF
and GPA. The present findings have implications for identifying sub-populations of
college students who may be at risk for misusing prescription stimulants and to
improve prevention and intervention strategies aimed at reducing misuse. Limitations
and suggestions for future research are discussed.
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INTRODUCTION
Prescription stimulant misuse, defined by Weyandt et al. (2014) “as the use of
stimulant medication in the absence of a valid prescription and use of prescription
stimulants other than as prescribed” (p.225), is a growing problem among college
students. Research suggests that 5.3% (Dupont et al., 2008; Poulin 2001) to 43%
(Benson et al., 2015; DeSantis, Webb & Noar, 2008; Weyandt et al., 2013a; 2014) of
college students have misused prescription stimulant medication in their lifetime.
Students found to be at greatest risk for misusing are those who are male, Caucasian,
members of a fraternity or sorority and who have a lower grade point average (GPA;
DuPaul et al. 2009; Dussault & Weyandt, 2013; Rabiner et al., 2009). Although those
with a lower than average GPA have been found to be at a heightened risk for misuse,
the academic consequences of misusing are largely unknown. Furthermore, research
also suggests deficits of executive functioning (EF) are associated with lower
academic achievement (Biederman et al., 2006) and increased likelihood of engaging
in risky behaviors (Pharo et al., 2011). It seems possible, therefore, that some students
who struggle academically may have problems with EF and are using prescription
stimulants to overcome EF deficits to succeed academically.
ADHD and Prescription Stimulant Use among Students
Stimulants such as Adderall and Ritalin are frequently prescribed for the
treatment of attention-deficit/hyperactivity disorder (ADHD), a disorder characterized
by clinically significant difficulties with inattention, impulsivity and/or hyperactivity.
ADHD is estimated to affect 3 - 7% of the school-aged population and 2.5 - 4.4% of
the adult population (American Psychiatric Association, 2013; Kessler et al., 2006).
2

This chronic and pervasive disorder, contrary to popular belief, is not outgrown by
adulthood and typically persists across the lifespan (Wilens, Farone, & Biederman,
2004). Interestingly, it is estimated that approximately 2% to 5% of college students
report clinically significant levels of ADHD symptomatology (DuPaul et al., 2001;
Janusis & Weyandt, 2010; Pryor et al. 2010; Weyandt et al., 2013b) and recent
estimates suggest that 5.9% of incoming college freshman have been diagnosed with
ADHD (Eagan et al., 2014). Research has repeatedly found that college students with
ADHD have poorer academic functioning compared to their non-diagnosed peers.
Heiligenstein et al. (1999) found that college students with ADHD had a significantly
lower mean GPA, were more likely to be on academic probation, and reported
significantly more academic problems compared to a non-ADHD. A recent study
conducted by Weyandt et al. (2013b) found that college students with ADHD reported
significantly lower grades on course assignments than non-ADHD control
participants. Research has also found that college students with ADHD had
significantly lower high school and college GPA, ACT scores, and withdrew from
significantly more classes than did non-ADHD students (Advokat, Lane, & Luo,
2011) and were less likely to graduate from college (Murphy, Barkley, & Bush, 2002).
For individuals who have ADHD, a plethora of research supports that
stimulant medications can be an effective treatment (eg. Kolar et al., 2008; Weyandt,
2006). In 2011, nearly 14 million monthly prescriptions for ADHD were written for
Americans ages 20-39 - two and a half times the amount written only four years earlier
(Schwarz, 2013). Corresponding with the growing number of prescriptions written for
stimulant medications, however, is a growing problem of misuse of these medications,
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i.e., using stimulant medication without a valid prescription or other than as
prescribed. Specifically, studies have found between 2.3% to 4.1% lifetime prevalence
for prescription stimulant misuse among high school students (Boyd, McCabe,
Cranford, & Young, 2006; McCabe, Teter, & Boyd, 2004) and between 5.3% (Dupont
et al., 2008; Poulin 2001) to 43% (Benson et al., 2015; DeSantis et al., 2008; Weyandt
et al., 2013a) of college students have reported misusing prescription stimulants during
their lifetime.
Prevalence, Risk Factors and Motivations of Prescription Stimulant Misuse
Numerous studies have documented that prescription stimulant misuse is a
growing problem among college students and that these medications are easily
accessible on college campuses. Studies consistently indicate that students commonly
obtain stimulants from peers and friends (DeSantis et al., 2008; Garnier et al., 2010;
McCabe et al., 2006; McNiel et al., 2011; Weyandt et al., 2013a). The first study to
assess prescription stimulant misuse was conducted in 2000 by Babcock and Byrne,
which reported that 16.4% of college students at a northeastern university endorsed
taking methylphenidate (MPH) for nonmedical purposes. More recent studies
exploring the misuse of prescription stimulants have reported prevalence rates among
college students that range from 5.3% to 43% (Benson et al., 2015; DeSantis et al.,
2008; Dupont et al., 2008; Weyandt et al., 2013a). For example, Garnier et al. (2010)
examined the prevalence of prescription medication diversion (defined as sharing,
selling, or trading to others who do not have a prescription) among college students
and found the most commonly diverted medication were prescription ADHD
medications (61.7% diversion rate). Similarly, Gallucci et al. (2015) found 58.9% of
4

college students with a current prescription had diverted their stimulant medication
during their lifetime and 32.4% had done so during the previous 30 days. Research has
found a higher rate of stimulant misuse associated with college students who are
Caucasian, male, members of sororities or fraternities and who have a lower GPA
(DuPaul et al., 2009; Dussault & Weyandt, 2013; Rabiner et al., 2009). A number of
psychological risk factors have been associated with prescription stimulant misuse,
including symptoms of inattention (Arria et al., 2011; Rabiner et al., 2009), anxiety,
stress, internal impulsivity, and internal restlessness (Dussault & Weyandt, 2013).
Indeed, a recent meta-analysis found ADHD symptoms were significantly associated
with prescription stimulant misuse (Benson et al., 2015). Further, Van Eck and
colleagues (2012), found disinhibition and conduct problem symptoms moderated the
association between ADHD symptoms and misuse of prescription stimulants among
college students. Researchers have also reported higher rates of prescription stimulant
misuse among students who engaged in substance use and other risky behaviors such
as drinking and driving (McCabe et al., 2005). The identification of predictors, such as
the academic and psychosocial functioning of students, is particularly important for
prevention and intervention strategies.
Although the misuse of prescription stimulants among college students is well
documented, the age at which individuals first start misusing prescription stimulants is
unclear and in fact, students may begin misusing prescription stimulants prior to
college. For example, White et al. (2006) conducted a study among college students,
and found 49% of students reported first misusing prescription stimulants in high
school and 51% reported first misusing in college. Furthermore, the study found a
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significant trend of misuse of prescription stimulants by students who attended a
private high school than by those who had attended a public high school. In a separate
study, Kroutil et al. (2006) found that individuals between ages 12 and 25 reported the
highest levels of prescription stimulant misuse in a sample of adolescents and adults.
A study conducted among medical students found students reported their first use of
prescription stimulants was in college (57%), followed by medical school (22%) and
then high school (12%; Emanuel et al., 2013). However, an important question that
remains unaddressed is whether the age of onset of prescription stimulant misuse is
related to a student’s academic outcomes (i.e., do students who begin misusing
prescription stimulants at a younger age have different academic outcomes compared
to students who begin misusing at older ages or not at all?). The present study
attempted to address this question.
Similarly, questions remain regarding the potential relationship between
frequency of misuse and academic outcomes. Preliminary studies suggest that a wide
range of frequency of prescription stimulant misuse exists; however, whether
frequency of misuse is related to academic outcomes has been unexplored. Regarding
frequency, White et al. (2006) found that 15.5% of college students who reported
misusing prescription stimulants did so 2 to 3 times per week, approximately half of
students (50.6%) did so 2 to 3 times per year and 33.9% of students did so 1 to 2 times
per month. A separate study also conducted among college students, found that 44.0%
of students who had misused prescription stimulants had only done so once or twice in
their lives, and the majority (85.3%) had used fewer than 12 times (Arria et al.,
2008b).
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Recently, a meta-analysis conducted by Benson and colleagues (2015) found
that of 15 studies that asked about motives for misuse, all of them reported that the
most commonly endorsed reasons were for academics. Similarly, a recent systematic
review by Weyandt et al. (2013a) found that 15 of 18 relevant studies identified the
primary motivation of college students misuse was for academic/cognitive reasons.
For example, Bossaer et al. (2013) found the top reason for prescription stimulant
misuse was to enhance alertness/energy (65.9%), followed by to improve academic
performance (56.7%) among students at an academic health sciences center.
Furthermore, Weyandt et al. (2009) found the highest reported reasons for stimulant
misuse among a sample of college students was to perform better on schoolwork,
perform better on tests and focus better in class. Judson and Langdon (2009) also
identified the primary motivations for misuse were to improve concentration and to
increase alertness and further suggested that academic performance pressures
significantly influence illicit use of prescription stimulants. In summary, research
investigating prescription stimulant misuse indicates significant numbers of college
students are misusing prescription stimulants for academic/cognitive enhancement;
yet, there is a lack of information regarding frequency of misuse and academic
outcomes.
Prescription Stimulant Misuse and Academic Performance
Although academic enhancement has consistently been reported as the primary
motive for students to engage in misuse of prescription stimulants, studies have found
misuse to be negatively associated with academic performance (Advokat et al., 2008;
McCabe et al., 2005; Weyandt et al., 2009). For example, Arria et al. (2008)
7

conducted a study among first-year college students and found that those who engaged
in misuse of prescription stimulants had poorer study skills (e.g., skipped classes more
often, spent less time studying, and more time socializing) and poorer academic
performance (e.g., lower GPAs in high school and college) compared to those who
had never misused. Furthermore, results indicated past-year misuse of prescription
stimulants predicted lower GPA by the end of the first year of college, which was
mediated by skipping class (Arria et al., 2008). Procrastination and difficulty with time
management have also been shown to relate to stimulant misuse among college
students (Moore et al., 2014).
In addition to students with low GPAs being among those at the highest risk
for misuse, research suggests that high-achieving students may also be attracted to and
engage in misuse of prescription stimulants due to the perceived effectiveness in
increasing alertness and academic productivity. Support for this is provided by studies
that have found the prevalence rates of prescription stimulant misuse were higher at
colleges with more restrictive admissions (McCabe et al., 2005). Specifically, McCabe
et al. (2005) examined the prevalence rates of prescription stimulant misuse among
students from 119 nationally represented 4-year colleges in the United States and
found the aggregate past year prevalence rates of misuse at individual colleges ranged
from 0% to 25%, with 12 schools having a prevalence of 10% or higher. More than
80% of those schools with a prevalence of 10% or higher had highly competitive
admissions standards. Medical students have also been suggested to be at high risk for
misusing prescription stimulants. Tuttle et al. (2010) found 10% of medical students
reported using stimulants to improve academic performance. Similarly, the misuse of
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prescription stimulants appears to be high among student pharmacists (6.7%; Lord et
al., 2003) and dental and dental hygiene students (12.4%; McNiel et al., 2011).
Collectively, research indicates significant numbers of students are misusing
prescription stimulants to enhance their academic performance. Students who perceive
themselves as struggling academically (i.e. receiving low grades, having difficulty
attending class and studying) appear to be particularly vulnerable to misuse. Indeed,
researchers have suggested “students may turn toward ADHD medication in an effort
to treat their attention difficulties” (Rabiner et al., 2008, p. 10). Given the fact that EF
skills are necessary for time management, organization, problem solving and
motivation, all of which are critical abilities for college students to succeed
academically, it is plausible that students experiencing deficits in EF are using
prescription stimulants in an effort to self-treat their difficulties. Furthermore, research
has found that individuals with EF deficits often tend to engage in more risky behavior
(such as misusing drugs) compared to those without EF deficits (Pharo et al., 2011).
Although multiple risk factors for misusing prescription stimulants have been
identified, the possible contribution of EF deficits and academic outcomes has not
been investigated.
Executive Functioning among College Students
Executive functioning (EF) has been defined as “higher-order cognitive
abilities that allow for strategic planning, cognitive flexibility, self-regulation and
goal-directed behavior” (Weyandt, 2005, p. 1). EF includes abilities such as
components of attention, reasoning, planning, inhibition, set-shifting, interference
control and working memory (Pennington & Orzonoff, 1996; Weyandt & Willis,
9

1994) and are considered critically important for complex human behavior
(Biederman et al., 2011). Although researchers have found significantly more adults
with ADHD, compared to non-ADHD participants, suffer from EF deficits, it is
important to note that EF deficits are not unique to ADHD (Weyandt, 2009; Weyandt
et al., 2014). For example, individuals with bipolar disorder have been found to
perform poorly on EF tasks (Dickstein et al., 2004) as well as individuals with
schizophrenia (Hedge et al., 2013). Irrespective of clinical status, however, deficits of
EF are associated with lower academic achievement (Biederman et al., 2006). For
example, Biederman et al. (2006) examined the association between deficits in EF and
functional outcomes among young adults with ADHD and a comparison non-ADHD
group and found deficits of EF were associated with lower academic achievement,
independent of an ADHD diagnosis. The authors suggested “that deficits of executive
functioning alone cause impairment in educational outcomes, and this is compounded
by the impairment caused by ADHD” (p. 1736). Similarly, a study conducted by
Dvorsky and Langberg (2014) found student-rated EF organizational skills and
motivation longitudinally predicted the overall academic impairment of college
students with ADHD. Given the demands college students often face, both
academically and socially, key aspects of EF such as planning, organization and
inhibition are crucial for their daily life.
In addition, individuals with EF deficits often also have deficits in response
inhibition, act impulsively, and fail to consider the consequences of their actions.
Thus, they tend to engage in more risky behavior (such as misusing drugs) compared
to those without EF deficits (Pharo et al., 2011). Indeed, Janusis and Weyandt (2010)
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found that college students with higher rates of sensation seeking were more likely to
misuse prescription stimulants. Furthermore, a recent study by Langberg et al. (2015)
found that EF deficits in self-motivation mediated the relationship between ADHD
symptoms and negative consequences of alcohol use among a sample of college
students. Given the impaired abilities of students suffering from EF deficits, it follows
that they may be at a heightened risk to engage in prescription stimulant misuse in
college. Clearly, further research is needed to evaluate a possible role that EF plays in
prescription stimulant misuse and academic outcomes. Specifically, if students with
EF deficits are found to be more at risk to misuse, efforts could be made to identify
those students and provide them with appropriate support and education.
Prescription Stimulants and Executive Function
Recent studies suggest that prescription stimulants are effective in not only
reducing ADHD symptoms but may improve executive function in individuals
diagnosed with ADHD. For example, the prescription stimulants methylphenidate and
amphetamine/D-amphetamine have been associated with improved EF performance in
children with ADHD and EF impairments (Kempton et al., 1999). Specifically,
Kempton et al. (1999) used computerized neuropsychological tests to assess EF in 30
children with ADHD (15 stimulant-naive and 15 stimulant-medicated) and 15
controls. Results indicated that the stimulant-naive ADHD children were impaired on
tasks of EF, including planning ability, movement time, attentional set shifting and
spatial working memory. In comparison, the group of medicated children with ADHD
showed no impairment on any EF tasks except for deficits in spatial recognition
memory. More recently, the first double-blind, placebo-controlled, crossover study
11

conducted with college students with ADHD found the stimulant medication,
lisdexamfetamine dimesylate (LDX) was associated with significant improvement in
both EF and ADHD symptoms (DuPaul et al., 2012). The study examined the effects
of LDX in 24 students with ADHD compared to 26 students without the disorder who
did not take LDX. Results from the study revealed LDX was associated with
statistically significant main effects for specific aspects of EF related to task
management, planning, organization, study skills and working memory compared to
nonmedication baseline and placebo. In individuals with ADHD taking LDX, results
revealed clinically significant reductions in ADHD symptoms, substantial
improvements in EF, and positive effects of psychosocial functioning. Despite the
large effect sizes and robust findings in the area of EF, what remains unknown is
whether prescription stimulants improve EF of individuals, and in particular college
students without ADHD. Weyandt et al. (2013a) and others have recommended that
research explore whether prescription stimulants are truly neurocognitive enhancers. A
recent study by Ilieva et al. (2013), found Adderall to have no more than small effects
on cognition in a study of 46 healthy young adults, yet users believed the drug
enhanced their performance.
Currently, the findings are mixed with regard to the effectiveness of
prescription stimulants as neurocognitive enhancers. A recent meta-analysis
(Marraccini, 2015) found that ADHD medication may act as a neuorocognitive
enhancer, but only for specific domains of cognition. A review regarding the use of
prescription stimulants for cognitive enhancement by Smith and Farah (2011) reported
effects of prescription stimulants on executive functions of working memory and
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cognitive control were mixed but have been found for some individuals on some tasks.
Furthermore, the authors concluded prescription stimulants might have positive effects
on learning for healthy adults. Similarly, a review by Advokat (2010) concerning
cognitive effects of amphetamine and MPH in ADHD and non-ADHD individuals had
mixed findings. Studies of adults without ADHD suggest prescription stimulants do
not promote acquisition of new information or facilitate cognitive plasticity but they
might improve retention of previously acquired information and facilitate memory
consolidation (Advokat, 2010). It is not clear, however, if improvement occurs only
for those having a baseline deficit in EF. A recent study found that MPH did not have
an overall enhancing effect on attention in healthy adults but suggested that perhaps
MPH enhances specific cognitive processes that were not assessed in their study (Ter
Huurne et al., 2015). Recently, Weyandt and colleagues (2014) conducted a systematic
review of the literature and found pro-stimulants were associated with improvement in
EF tasks and some domains of cognition for adults including college students.
Although science has not fully addressed the issue of whether stimulants are
neurocognitive enhancers for those without ADHD, it is clear that college students
without ADHD are misusing prescription stimulants for academic purposes and that
the rates of misuse are continuing to rise (Benson et al., 2015; Rabiner, 2013; Smith &
Farah, 2011; Weyandt et al., 2013a).
Purpose of the Study
Previous research has found that a significant number of college students in the
USA and abroad are misusing prescription stimulant medication (Benson et al., 2015;
Jensen, Forlini, Partridge, & Hall, 2016). Students who are at greater risk for misusing
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prescription stimulants include those who are white, have low GPAs, and are members
of fraternities and sororities (Dussault & Weyandt, 2013; Rabiner et al., 2009). The
primary reason reported for stimulant misuse among college students is academic
enhancement i.e., to perform better on schoolwork, perform better on tests and focus
better in class (DeSantis et al., 2008; Dussault & Weyandt, 2013; Graff Low &
Gendaszek, 2002; Judson & Langdon, 2009; Lookatch et al., 2012; Rabiner et al.,
2009; Weyandt et al., 2009). It is possible that students who have greater difficulty
with planning, organization, self-motivation, and interference control (i.e., EF deficits)
are misusing prescription stimulants to help them overcome these deficits to succeed
academically. Preliminary findings investigating EF in college students has revealed
that individuals with deficits in EF are more likely to have educational difficulties and
take part in risky behavior, and that executive functions are substantially improved in
students with ADHD when taking prescription stimulants (Dupaul et al., 2012;
Kempton et al., 1999). To date, however, no study has investigated the relationship
between prescription stimulant misuse, EF, and educational outcomes among college
students. Results from such a study would be useful in designing prevention and
intervention programs. Therefore, the purpose of the present study was to examine the
relationship between prescription stimulant misuse, EF and academic outcomes in a
large sample of college students from five regions of the United States.
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Specifically, it was hypothesized that:
1) Students who self reported EF deficits would be more likely to report
misusing prescription stimulants than students who self reported normal EF skills (i.e.,
no EF deficits as measured by the total score on the Barkley Deficits in Executive
Functioning Scale).
2) Students who reported below or above average academic outcomes would
be more likely to report misusing prescription stimulants than students who reported
average academic outcomes (average referring to C GPA; 2.0 on a 4.0 scale).
3) Prescription stimulant misuse would moderate the relationship between EF
and academic performance. Specifically, prescription stimulant misuse was expected
to alter the strength and/or direction of the relationship between EF and academic
performance.
A secondary purpose of this study was to explore the onset of prescription
stimulant misuse, frequency of misuse, and academic outcomes. It was predicted that
the earlier the onset (pre-college) and the greater the frequency of prescription
stimulant misuse, the more likely students would report lower academic outcomes i.e.,
it was hypothesized that there would be a negative correlation between years of
prescription stimulant misuse and frequency, and academic performance.
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METHODS
Procedures
The current study was approved by University of Rhode Island Institutional
Review Board (IRB). University staff and faculty from six public universities located
in regions of the United States: Northeast, Southeast, Central-Midwest, Northwest and
Southwest were contacted via email with a description of the proposed study and a
request to help with recruitment of participants. Schools from various regions were
included in order to obtain a diverse, geographically representative sample of
participants. Reported demographics of each university from the 2015-2016 Common
Data Set (CDS) is included in Appendix F. Faculty and staff were asked to distribute
the email containing the link to students who may be eligible and willing to
participate. To further facilitate participant recruitment, the same information was
posted on public university Facebook webpages. Interested participants were
instructed to enter a secure and encrypted site and instructed to confirm they had read
and understood the content by checking a statement of endorsement. The consent form
(Appendix A) contained the researchers’ contact information should participants have
had questions or concerns and listed the requirements and responsibilities of
participating in the study, including a description of the research project, as well as
any potential for harm, confidentiality and benefits of participating. Participants were
made aware that the survey was completely voluntary and anonymous and that they
had the opportunity to discontinue participation in the study at any time. Participants
who provided consent were presented with electronic versions of three measures, each
of which is described in detail below: a demographic survey designed by researcher,
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Stimulant Survey Questionnaire (SSQ; Weyandt et al., 2009) and Barkley Deficits in
Executive Functioning Scale for Adults (BDEFs for Adults; Barkley, 2011). After
completing all measures, students were debriefed and provided with information
regarding how to contact the researcher directly if desired.
Participants
A total of 314 individuals completed the survey between November 2015 and
March 2016. The present sample included N = 308 undergraduate participants from
six public US universities. The remaining six participants reported being of graduate
student status (n = 5), or reported attending a university not included in the study (n =
1). Sample size was calculated a priori based on the primary aim of the study. A power
analysis using G Power 3.1 (Faul, Erdfelder, Lang, & Buchner, 2007) indicated a
sample size of at least 128 is estimated to achieve 80% power to detect a medium
effect size and assuming an alpha of .05. Thus, the sample size of the present study is
sufficient.
The mean age of participants was 20.77 years (SD = 3.59; range 18-57 years). A
little over half of the participants were enrolled at a university in the Northeastern
United States (52.6%), 19.2% were enrolled at a university in the Central-Midwest,
18.2% were enrolled in a university in the Southwest, 5.8% were enrolled in a
university in the Northwest, and 4.2% were enrolled in a university in the Southeast.
The majority of participants were female (73.4%), and 26.6% identified as male. A
large percentage of participants identified as White (74.0%), 3.6% identified as Black
or African American, 7.8% identified as Asian, 0.3% identified as American Indian or
Alaska Native, 1.0% identified as Native Hawaiian or Other Pacific Island and 13.3%
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selected Other. Further information concerning participant demographics can be found
in Table 1.
Measures
Demographic Information
A demographics questionnaire (Appendix B) was administered, which included
questions about age, gender, ethnicity, degree program and current diagnosis of
ADHD. Students were asked questions related to their academic performance in
college for example, “What is your cumulative GPA?” “How many hours per week on
average do you spend studying?” “How many classes do you skip per week?”.
Stimulant Survey Questionnaire (SSQ)
The SSQ (Weyandt et al., 2009) is a 40-item questionnaire that measures the
use and misuse of prescription stimulant medications in college students (Appendix
C). Items on the survey are statements with a 5-point Likert-type scale response (1=
never, 2 = rarely, 3 = occasionally, 4 = frequently, 5 = always) in the first section, and
a yes-or-no response in the second section. The total score ranges from 40 to 170, with
a higher score indicating more prescription stimulant medication use and misuse.
Several additional questions were added to the SSQ to further investigate patterns of
use related to onset and frequency of misuse (Appendix D). The SSQ has been found
to have adequate internal consistency with a Cronbach’s alpha coefficient of .85.
(Weyandt et al., 2009). Based on factor analysis (Weyandt et al., 2009), the SSQ
consists of four factors including Self-Reported Prescription Stimulant Misuse,
Perception of Prevalence of Prescription Misuse among Peers, Knowledge of Atypical
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Stimulant Misuse among Peers, and Perception of Safety of Stimulants (further
information regarding the factors is included in Appendix E). The Self-Reported
Prescription Stimulant Misuse score was used as a continuous outcome variable. For
group analyses, self-reported prescription stimulant misuse (i.e., those who endorsed
having misused prescription stimulants and those who did not) was used as a binary
variable.
Barkley Deficits in Executive Functioning Scale (BDEFS for Adults)
The BDEFS for Adults (Barkley, 2011) is an empirically and theoretically
based instrument used to evaluate dimensions of adult EF in daily life. The 89-item
rating scale is intended for adults aged 18-81 years and used to generate a Total EF
Summary Score, with higher scores indicating higher EF deficiencies thus poorer EF
skills. Based on factor analysis, the BDEFS consists of five factors: Self-Management
of Time, Self-Organization and Problem Solving, Self-Restraint, Self-Motivation, and
Self-Regulation of Emotion. Each item is rated using a four- point scale (1 = never or
rarely, 2 = sometimes, 3 = often, 4 = very often). The BDEFS for Adults has
demonstrated good reliability as evidenced by high internal consistency (Cronbach's
alpha ranging from .91 to .95 scores across the five scales); good inter-observer
agreement (.66 to .79 across scales); and high test–retest reliability over a 2–3 week
interval (ranging from .62 to .90 across scales and .84 for the Total EF Summary
Score). The Total EF Summary Score was used as a continuous variable in correlation
and regression analyses. For group analyses, clinically significant groups of high EF
deficits were examined in comparison to the dependent variables.
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RESULTS
Data Analyses
Preliminary assumption testing was conducted following guidelines by
Tabachnick & Fidell (2007). Data were examined with regard to assumptions of
unequal sample sizes, missing data, normality, linearity, outliers, homogeneity of
variance, homogeneity of regression, ratio of cases to independent variables,
normality, linearity, homoscedasticity, outliers and multicollinearity. Given the group
endorsing prescription stimulant misuse was much smaller than the group not
endorsing prescription stimulants, the sample sizes were unequal however they were
sufficiently large to ensure normality of the sampling distribution (Tabachnick &
Fidell, 2007). At the individual item level data, missing data ranged from 0% to 1%.
Missing data were handled using listwise deletion.
Descriptive Statistics
Overall prevalence of lifetime prescription stimulant misuse was 18.8%. There
were not significant differences in misuse based on gender, F (1, 306) = .709, p =
.401), 17.7% of females reported misusing and 22.0% of males reported misusing. The
three most frequently reported reasons for prescription stimulant misuse were
academically related (see Table 4). A substantial number of participants reported
knowing students who use prescription stimulants while studying (71.4%), during
finals week (70.5%) and during tests (62.7%). In terms of availability, 44.1% of
participants agreed that prescription stimulants were easy to get on their campus and
32.5% neither agreed nor disagreed. With regards to psychological conditions,
participants reported a diagnosis of anxiety (32.1%), depression (27.6%), eating
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disorder (7.8%), specific learning disability (3.2%) and 59.4% did not report any
psychological conditions.
With regard to EF deficits, based on BDEFs score, 64.6% of participants were in
the normal range of EF and 35.4% of participants displayed some level of clinical
significant EF deficits (see Table 3). With regard to academic outcomes, reported
GPA ranged from 1.50 to 4.00, the mean equal to 3.29 (SD = 0.48). Only three
participants reported a GPA below 2.0. Hours spent studying per week ranged from 0
to 60 hours (M = 14.10, SD = 10.49). Classes skipped per week ranged from 0 to 9 (M
= 0.47, SD =1.05). In order to standardize classes skipped across varying class
sessions in schedule, the percent of classes skipped was calculated ([number of class
sessions skipped/number of class session scheduled] x 100) (Arria et al., 2008). The
majority of participants reported not skipping any class sessions (72.7%).
With regard to onset, only 1% of participants reported misusing prescription
stimulants in elementary school, 2.9% reported misusing prescription stimulants in
middle/ junior high school, 8.4% reported misusing in high school and 20.5% reported
misusing in college (see Table 6). It is interesting to note that more participants
(20.5%) reported misusing specifically in college than when asked about misusing
prescription stimulants ever (18.8%).
Prescription Stimulant Misuse and Executive Functioning
To test the first hypothesis, that students who reported EF deficits would report
misusing prescription stimulants more than students who reported normal EF skills
(i.e., no EF deficits), an independent samples t-test was conducted with the
independent variable group (EF deficits or no EF deficits; dichotomous) and the
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dependent variable being the Self-Reported Prescription Stimulant Misuse subscale
score of the SSQ (continuous). There was heterogeneity of variances, as assessed by
Levene’s test of homogeneity of variances (p < .001), therefore Welch’s t-test, an
alternative to the standard t-test, was run in addition to the t-test to account for this
violation. Results revealed statistically significant group differences according to
Welch’s t-test, t (143.787) = 4.707, p < .001, Cohen’s d = 0.603. The group with
clinically significant EF deficits had higher scores on the Self-reported Prescription
Stimulant Misuse (M = 35.31, SD = 14.56) compared to the group with no clinical EF
deficiencies (M = 28.24, SD = 7.92). This finding supports the hypothesis and
indicates students with self reported executive functioning deficits (i.e., lower
executive functioning skills) were more likely to report misuse of prescription
stimulants.
Prescription Stimulant Misuse and Academic Functioning
To test the second hypothesis, that students who reported below or above
average academic outcomes would report misusing prescription stimulants more than
students who reported average academic outcomes, a logistic regression was
performed using GPA, hours spent studying and classes skipped as a predictor
variables. A binomial logistic regression was performed to ascertain the effects of
GPA, hours spent studying and classes skipped, on the likelihood that participants
misuse prescription stimulants. To test the assumption of linearity, the linearity of the
continuous variables with respect to the logit of the dependent variable was assessed
via the Box-Tidwell (1962) procedure. Based on this assessment, all continuous
independent variables were found to be linearly related to the logit (logit is the natural
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logarithm of the odds, it reflects the probability of an event occurring; Cramer &
Howitt (2004) p. 94) of the dependent variable, thus indicating the assumption of
linearity was not violated. Outliers were assessed by standardized residuals greater
than ±2.5 standard deviations; three outliers (standard residual values of 2.606, 2.841
and 2.936) were identified and included in the analysis. The regression model was
found not to be statistically significant, χ2(3) = 3.165, p = .367.
Executive Functioning, Academic Functioning and Prescription Stimulants
To test the third hypothesis, that prescription stimulant misuse would moderate
the relationship between EF and academic outcomes, a two-way between subjects
ANOVA was performed. Prescription stimulant misuse (dichotomous) and EF groups
(dichotomous) served as the independent variables and GPA (continuous) served as
the dependent variable. Assumptions were tested prior to analysis in regard the
assumption of independence, unequal group size, normality and homogeneity of
variance. Outliers were assessed by standardized residuals greater than ±3 standard
deviations; three outliers (standard residual values of -3.56, -3.20 and -3.21) were
identified and included. The homogeneity of variance was assessed by Levene’s test of
homogeneity of variance, which was significant at the .05 level [F(3, 301) = 3.321, p =
.019) indicating violation of this assumption. However, given the interest in the
possible interaction, no modifications were made. Results revealed, there was a
significant main effect for EF Clinical group [F(1,301) = 7.316, p = .007, partial η2 =
.024] but not a statistically significant main effect for misuse on GPA [F(1,301) =
.019, p = .890, partial η2 = .000]. Furthermore, there was not a statistically significant
interaction effect [F(1,301) = .194, p = .660, partial η2 = .001], suggesting the effect of
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EF skills on GPA is the same for those who did and did not misuse prescription
stimulants.
Onset and Frequency of Misuse and Academics
To test the secondary hypothesis that students who reported earlier onset and
greater frequency of misuse of prescription stimulants would report poorer academic
outcomes, a multiple regression was performed using age of onset and frequency of
misuse as predictor variables. GPA served as the dependent variable. There was
independence of residuals, as assessed by a Durbin-Watson statistic of 1.774 (DurbinWatson statistic can range from 0 to 4, a value of approximately 2 indicates that there
is no correlation between residuals; Cohen et al., 2003). Multicollinearity, which
occurs when two or more independent variables are highly correlated with each other,
was not an issue, as assessed by variance inflation factor (VIF) values, which were all
below 10 (values above 10 are typically considered problematic), and by tolerance
values, which were all above .10 (values below .10 are typically considered
problematic; Cohen et al., 2003). The regression model did not statistically
significantly predict GPA, F (6, 298) = 1.881, p = .084, R2 = .036. Regression
coefficients and standard errors can be found in Table 9. A multiple regression was
also conducted, using hours spent studying as the dependent variable. Preliminary
correlations revealed small negative correlations for onset and frequency of misuse
and hours spent studying, however only frequency of misuse was found to be
significant (r = -.134, p = .009). This finding suggests that the more frequently
prescription stimulants were misused, the less number of hours spent studying. The
regression model, using onset and frequency as predictor variables and hours spent
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studying as the dependent variable, was not statistically significant, F (5, 302) = 1.651,
p = .146).
Interestingly, descriptive statistical analyses revealed that 7.1% of participants
agreed with the statement “Using prescription stimulants daily is harmless”, yet 24.7%
agreed with the statement “Using prescription stimulants occasionally is harmless”.
Furthermore, higher percentages of misuse were reported for each class year. More
specifically, only 10.0% of freshman reported misusing prescription stimulants, 14.9%
of sophomore, 22.4% of juniors and 25.0% of seniors reported misusing prescription
stimulants.
Additional Post Hoc Analyses
Additional post-hoc analyses were conducted to explore potential variations in
prescription stimulant misuse between universities and possible variations in
motivations for self-reported prescription use. Specifically, a one-way ANOVA was
conducted with university geographic region as the independent variable and SelfReported Stimulant Misuse subscale of the SSQ as the dependent variable, however
results were not significant suggesting no differences across universities.
In addition, preliminary Pearson product-movement correlations were
calculated to explore relationships between total and subscale scores of the SSQ and
the BDEFs (see Tables 10-14). Pearson product-moment correlations revealed that
self-reported stimulant use, as measured by Factor 1 subscale score on the SSQ, was
significantly correlated with all BDEFs subscales and total score, the strongest
correlation being with Self-Restraint (r = .513, p < .01), followed by Total EF score (r
= .421, p < .01), Self-Motivation (r = .400, p < .01), Self-Regulation of Emotions (r =
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.335, p < .01), Self-Organization/ Problem Solving (r = .321, p < .01), and SelfManagement of Time (r= .280, p < .01). The SSQ Total Score was correlated with all
the subscales and total score of the BDEFs, the strongest correlation being with SelfRestraint (r = .435, p < .01). These findings indicate that students with EF deficits,
(especially poor self-restraint as measured by the Self-Restraint subscale of the
BDEFs) are at increased risk to misuse prescription stimulants.
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DISCUSSION
A substantial body of research has found that a significant number of college
students are misusing prescription stimulant medication (Benson et al., 2015; Weyandt
et al., 2013a). Based on previous findings that suggest that college students are
misusing prescription stimulants primarily for academic reasons and that executive
functioning skills are crucial for academic success, the purpose of the present study
was to examine the relationship between prescription stimulant misuse, EF, and
academic outcomes A second purpose of this study was to explore the onset of
prescription stimulant misuse, frequency of misuse, and academic outcomes.
The study was the first to investigate the relationship between EF and prescription
stimulant misuse and academic outcomes among a relatively large sample of college
students from five regions of the USA.
The first hypothesis that students who reported executive functioning deficits
would be more likely to report misusing prescription stimulants, as assessed by the
Self-Reported Prescription Stimulant Misuse factor of the SSQ, than students who
reported normal EF, as assessed by the BDEFS was supported. Specifically results
revealed that students with self reported EF deficits had higher scores on the SelfReported Prescription Stimulant Misuse factor, indicating greater self reported misuse
of prescription stimulants. These findings are consistent with previous research
reporting procrastination and difficulty with time-management were more likely to
misuse prescription stimulants (Moore et al., 2014) and suggests that students with EF
deficits are more likely to misuse prescription stimulants than students with normal
EF. Although not causal, these findings suggest that individuals who have clinically
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significant EF deficits may be at greater risk for misusing prescription stimulant
medication. It is unknown if students with EF deficits are benefiting from prescription
stimulants, or what the effects are on their overall functioning. Prior research has
suggested that prescriptions stimulants may benefit those suffering from deficits, but
not improve abilities in healthy individuals not suffering from deficits (Mehta et al.,
2000; Smith & Farah, 2011). Future studies are needed to further understand the
relationship between EF deficits and prescription stimulants.
The second hypothesis, that students who reported below or above average
academic outcomes would be more likely to report misusing prescription stimulants
than students who reported average academic outcomes was not supported. Results
revealed, contrary to what was expected, that GPA, hours spent studying and classes
skipped were not useful in predicting students report of prescription stimulant misuse.
These findings are consistent with previous research by Advokat and colleagues
(2008) who also found that GPA was not related to misuse in a study of 1,550 students
at a public Southern university. However, these findings are inconsistent with studies
that have found students with lower GPAs to be associated with prescription stimulant
misuse (Arria et al., 2013; Garnier-Dykstra et al., 2012; Weyandt et al., 2013). It is
unknown if the GPA of those who reported misusing would be lower had they not
misused the prescription stimulants. In other words, it is unknown if the prescription
stimulants were effective in increasing and aiding in academic outcomes, and had the
students not misused, if their GPAs would be lower. A longitudinal study conducted
by Arria et al. (2008) found that past-year misuse of prescription stimulants predicted
lower GPA by the end of the first year of college, which was mediated by skipping
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class. Given the small percentage of students who reported skipping class, it is
unknown if this limited the present research findings. Future studies should investigate
additional academic outcome variables and conduct additional longitudinal research in
order to better understand the relationship between academic outcomes and
prescription stimulant misuse.
The third hypothesis, that prescription stimulant misuse would moderate the
relationship between EF and academic performance was partially supported.
Specifically, prescription stimulant misuse was expected to alter the strength and/or
direction of the relationship between EF and academic performance. As expected,
participants with EF deficits had lower GPAs. However, results from a two-way
ANOVA were not statistically significant for an interaction effect. Results were only
significant for a main effect of EF Clinical group. These findings are consistent with
previous research that found deficits of EF were associated with lower academic
achievement (Biederman et al., 2006; Dvorsky & Langberg, 2014) and indicate that
EF deficits are likely to cause impairment in academic outcomes. Furthermore, the
effect of EF skills on GPA does not appear to be moderated by prescription stimulant
misuse. It is unknown if the students reporting EF deficits received any additional
academic skills assistance (such as time management or study skills assistance), and if
so, it is unknown how academic skills assistance contributes to the relationship
between EF, academic outcomes and prescription stimulant misuse. Future studies
need to further explore the relationship other variables that may be affecting EF
deficits, academic outcomes and misuse of prescription stimulants.
Onset and Frequency of Prescription Stimulant Misuse and Academic Outcomes
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A second purpose of this study was to explore the onset of prescription stimulant
misuse, frequency of misuse, and academic outcomes. The hypothesis that the earlier
the onset (pre-college) and the greater the frequency of prescription stimulant misuse,
the more likely students would be to report lower academic outcomes was not fully
supported. It was predicted there would be a negative correlation between years of
prescription stimulant misuse and frequency, and academic performance. Preliminary
results revealed that while frequency and onset of reported prescription stimulant
misuse were negatively correlated with hours spent studying, only frequency of
reported misuse, was statistically significant. These findings are consistent with
previous research that found college students who misuse prescription stimulants spent
less time studying (Arria et al., 2008) and suggests that students may be misusing
prescription stimulants to catch up on studying and cram last minute for an exam. It is
unknown if students who misuse prescription stimulants more frequently, are actually
benefitting from the drug and able to get their work done more efficiently, therefore do
not need to study as long or as has been suggested, it students are misusing
prescription stimulants to compensate for not studying till the last minute. Results
from the regression models revealed that frequency and onset of prescription stimulant
misuse were not statistically significantly in predicting hours spent studying or GPA.
This finding is inconsistent with longitudinal research that has found misuse of
prescription stimulants predictive of GPA (Arria et al., 2008). It is unknown the
effects the prescription stimulants have on the students, it could be that the students
who misused prescription stimulants were struggling academically when they began
misusing, and use the drugs to achieve average academic outcomes. Future
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longitudinal research is needed to determine if frequency and/or onset of prescription
stimulants misuse are predictive of academic outcomes.
Furthermore, students appear to perceive occasional use of prescription stimulants
safer than daily misuse. This finding is consistent with previous research that has
found college students perceive prescription stimulants as safe (Low & Gendaszek,
2002) and indicates that students perceive using prescription stimulants once in a
while (for example, during finals week) is safe. Prior research has reported that
perceived risk of prescription stimulants is negatively correlated with misuse (Judson
& Langdon, 2009), i.e. students who reported being more aware of the risks, were less
likely to report misusing. Future intervention and preventative strategies need to
educate students on the risks associated with prescription stimulant misuse.
Consistent with previous research (McCabe, Teter & Boyd, 2004; Austic, 2015),
participants reported higher rates of misuse while in college than in high school,
middle/ junior high school and elementary school. Specifically, approximately 3% of
participants reported misusing in middle/ junior high school and nearly 10% misusing
in high school. This finding is consistent with previous studies that have reported
prevalence rates among adolescents that range from 1.7% (Herman-Stahl, Krebs,
Kroutil, & Heller, 2006) to 8.3% (Whiteside et al., 2015). Studies that were conducted
among middle school and high schools students reported 2.3% to 4.5% lifetime
prevalence for prescription stimulant misuse (Boyd, McCabe, Cranford, & Young,
2006; McCabe, Teter, & Boyd, 2004). In a separate study conducted among high
school seniors, 7.4% reported misusing Adderall in 2013 and 6.8% reported misusing
the drug in 2014 (Johnston, OMalley, Miech, Bachman, & Schulenberg, 2015).
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Furthermore, a recent study based on data from 240,160 adolescents and young adults
(ages 12-20) reported the peak ages to start misusing prescription stimulants are
between the ages of 16 and 19 (Austic, 2015). Thus, current findings in conjunction
with previous research suggests that students are misusing prescription stimulants
prior to college, and it is important that preventative measures are taken aimed at
middle and high school aged children. Future studies should explore whether motives
for misuse are different for younger students compared to college students.
Current results also revealed that reported misuse of prescription stimulant
medication increased with year in college. More specifically, 10.0% of Freshman,
14.9% of Sophomores, 22.4% of Juniors, and 25.0% of Seniors reported misusing.
This finding is consistent with previous studies (DeSantis et al., 2008; McCabe et al.,
2006), and it has been suggested this may be due to upperclassmen having been in
college longer, therefore had more time and opportunities to misuse. An alternative
explanation is that upperclassman have more peer pressure and/or academic pressure
which contribute to their increased rates of misuse.
Correlational analyses explored the relationships between self-reported
prescription stimulant misuse and aspects of EF. Analyses revealed that self-reported
prescription stimulant misuse was correlated with Self-Restraint, Self-Motivation,
Self-Management of Time, Self-Organization/ Problem Solving, and Self-Regulation
of Emotions. Although these observed relationships are not causal in nature, it is
reasonable to consider each as a potential risk factor for prescription stimulant misuse
among undergraduate students, and to use this information to inform future
investigations upon which prevention and intervention strategies may be based.
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Limitations and Future Directions
Several limitations of the present study should be discussed. First, the current
study employed a convenience sample, which may limit the generalizability of the
findings. Second, the sample was disproportionately White and female, which also
limits the generalizability of the findings. Future research should attempt to acquire a
more proportionate number of students from various universities. Third, the study was
voluntary, thus students who participated may not be representative of the entire
population, as they may have had a special interest in the topics of this survey. Fourth,
this study relied on self-reported data, and although we have no indication that
underreporting occurred, due to the sensitive nature of the questions, the possibility of
response bias and social desirability bias cannot be ruled out. Fifth, as the study was
correlational in design no causal inferences regarding the relationship between the
variables of interest can be made.
Future studies regarding the relationship between prescription stimulant misuse,
EF and academic outcomes are needed. Ideally, such studies would be longitudinal
and may benefit from the use of academic outcomes collected directly from the
universities’ registrar’s office so as to not rely so heavily on self-reported outcomes.
Future studies should consider including questions that ask about the dosage that
students are misusing. Future research should also consider including students enrolled
in private universities as well as community colleges. It is also important that future
studies consider investigating prescription stimulant misuse and its relationship with
EF among high school and middle or junior high school students.
Conclusions
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In conclusion, this study was the first to investigate the relationship between
prescription stimulant misuse, EF and academic outcomes among college students. A
substantial percentage, 18.8%, of college students in this study reported misusing
prescription stimulants and males and females did not differ in rates of reported
misuse. The three most frequently reported reasons for prescription stimulant misuse
were academically related. Additionally, substantial proportions of participants
reported knowing students who use prescription stimulants for academic reasons. As
hypothesized individuals identified as having clinically significant levels of EF
deficits were significantly more likely to report misusing prescription stimulants.
Participants with EF deficits reported significantly lower GPAs than individuals with
normal EF, and prescription stimulant misuse was not found to moderate this
relationship. The present study has many important implications for prevention and
intervention policies on college campuses, specifically in identifying those at risk for
misusing prescription stimulants.

34

TABLES
Table 1.1: Participant Demographics
Category
Gender
Female
Male
Race/ Ethnicity
White
Black or African American
Asian
American Indian or Alaska Native
Native Hawaiian or Other Pacific
Island
Biracial
Chican@/Latin@
Hispanic
Hispanic/Latino
Hispanic/White
Human
Latina/o
Mexican
Mexican-American
Mixed
More than 1 Race
Multiracial
Non-white
Peruvian
Class year
Freshman
Sophomore
Junior
Senior
Member of a sorority or fraternity
Yes
No
ADHD diagnosis
Yes
No
High school
Public
Private
Other
Intend to purse graduate school
Yes
No

N

Percent

226
82

73.4%
26.6%

228
11
24
1
3

74.0%
3.6%
7.8%
0.3%
1.0%

1
1
12
1
2
1
7
1
1
2
1
1
8
1

0.3%
0.3%
3.9%
0.3%
0.6%
0.3%
2.3%
0.3%
0.3%
0.6%
0.3%
0.3%
2.6%
0.3%

60
74
98
76

19.5%
24.0%
31.8%
24.7%

57
251

18.5%
81.5%

39
269

12.7%
87.3%

263
38
7

85.4%
12.3%
2.3%

247
61

80.2%
19.8%
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Table 1.2: Participant Demographics- Psychological Conditions

Category

N

Percent

Psychological conditions
Anxiety

28

9.1%

1

.3%

48

15.6%

1

.3%

2

.6%

1

.3%

9

2.9%

1

.3%

Anxiety, Depression, Specific learning disability

3

1.0%

Anxiety, Eating disorder

3

1.0%

Anxiety, Specific learning disability

2

.6%

16

5.2%

3

1.0%

1

.3%

4

1.3%

183

59.4%

2

.6%

Anxiety, Bipolar disorder
Anxiety, Depression
Anxiety, Depression, Bipolar disorder
Anxiety, Depression, Bipolar disorder, Eating
disorder
Anxiety, Depression, Bipolar disorder, Eating
disorder, Specific learning disability
Anxiety, Depression, Eating disorder
Anxiety, Depression, Eating disorder, Specific
learning disability

Depression
Depression, Eating disorder
Depression, Eating disorder, Specific learning
disability
Eating disorder
None of the above
Specific learning disability
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Table 1.3. Participant Demographics- College Major(s)
Category

N

Business Administration

Percent
10

3.2

1

.3

1

.3

Business Administration, Humanities and Social Sciences

3

1.0

Business Administration, Languages and Literature

1

.3

Business Administration, Mathematics and Computer Science

1

.3

Business Administration, Natural and Physical Science

1

.3

Communication and Media

8

2.6

Communication and Media, Environmental Studies

1

.3

Communication and Media, Humanities and Social Sciences

1

.3

1

.3

1

.3

1

.3

10

3.2

Education, Humanities and Social Sciences

4

1.3

Education, Political and Global Studies

1

.3

15

4.9

Engineering, Environmental Studies

1

.3

Engineering, Healthcare and Clinical Sciences

1

.3

Engineering, Languages and Literature

2

.6

Engineering, Mathematics and Computer Science

4

1.3

Engineering, Natural and Physical Science, Undecided/

1

.3

Business Administration, Communication and Media
Business Administration, Engineering, Languages and
Literature

Communication and Media, Mathematics and Computer
Science
Communication and Media, Natural and Physical Science
Communication and Media, Visual and Performing Arts and
Design
Education

Engineering

37

Engineering, Natural and Physical Science, Undecided/

1

.3

11

3.6

Environmental Studies, Healthcare and Clinical Sciences

1

.3

Environmental Studies, Natural and Physical Science

4

1.3

1

.3

1

.3

82

26.6

5

1.6

Healthcare and Clinical Sciences, Natural and Physical Science

3

1.0

Healthcare and Clinical Sciences, Undecided/ Undeclared

1

.3

77

25.0

Humanities and Social Sciences, Natural and Physical Science

3

1.0

Humanities and Social Sciences, Political and Global Studies

3

1.0

Languages and Literature

1

.3

Languages and Literature, Natural and Physical Science

3

1.0

Languages and Literature, Political and Global Studies

3

1.0

Mathematics and Computer Science

6

1.9

19

6.2

Natural and Physical Science, Undecided/ Undeclared

1

.3

Political and Global Studies

7

2.3

Undecided/ Undeclared

5

1.6

Visual and Performing Arts and Design

1

.3

Undeclared
Environmental Studies

Environmental Studies, Natural and Physical Science, Visual
and Performing Arts and Design
Environmental Studies, Political and Global Studies
Healthcare and Clinical Sciences
Healthcare and Clinical Sciences, Humanities and Social
Sciences

Humanities and Social Sciences

Natural and Physical Science
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Table 1.4. Participant Demographics- Age and Academics
Standard
Mean

Deviation

Minimum

Maximum

Age

20.77

3.585

18

57

GPA

3.292

.482

1.50

4.00

9.80

4.193

1

21

14.10

10.489

0

60

.469

1.049

.0

9.0

4.73

4.223

0

23

How many class
sessions are in your
schedule each week?
How many hours per
week on average do
you spend studying?
How many classes do
you typically skip per
week (fill in number of
classes)?
Number of hours
typically spent
exercising per week
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Table 1.5. Participant Demographics- University Regions
Region

N

Percent

Northwest

18

5.8

Southeast

13

4.2

Southwest

56

18.2

Central Midwest

59

19.2

Northeast

162

52.6
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Table 2.1. Prescription Stimulant Misuse: Academic outcomes

Have you ever misused a prescription stimulant
medication?
No

GPA
How many class sessions are in
your schedule each week?
How many hours per week on
average do you spend studying?
Standardized Class Sessions
Skipped

Yes

Mean

Standard
Deviation

Mean

Standard
Deviation

3.294

.496

3.281

.423

9.97

4.216

9.09

4.049

14.54

10.815

12.19

8.779

4.709

10.299

5.933

13.249

.406

.9304

.741

1.4334

How many classes do you
typically skip per week (fill in
number of classes)?

Table 2.2. Prescription Stimulant Misuse: Class Year
Have you ever misused a prescription stimulant
medication?
No
Yes
Count

Row N %

Count

Row N %

Class Freshman

54

90.0%

6

10.0%

Year

Sophomore

63

85.1%

11

14.9%

Junior

76

77.6%

22

22.4%

Senior

57

75.0%

19

25.0%
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Table 2.3. Prescription Stimulant Misuse: Gender

Gender

Total

Female Count
% within
Gender
% within
Misused
stimulant
medication
% of Total
Male
Count
% within
Gender
% within
Misused
prescription
stimulant
medication
% of Total
Count
% within
Gender
% within
Misused a
prescription
stimulant
medication
% of Total

Have you ever misused a
prescription stimulant
medication?
No
Yes
186
40

Total
226

82.3%

17.7%

100.0%

74.4%

69.0%

73.4%

60.4%
64

13.0%
18

73.4%
82

78.0%

22.0%

100.0%

25.6%

31.0%

26.6%

20.8%
250

5.8%
58

26.6%
308

81.2%

18.8%

100.0%

100.0%

100.0%

100.0%

81.2%

18.8%

100.0%
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Table 3. Executive Functioning Clinical Significance
Cumulative
EF Clinical Significance

Percent

EF is not abnormal

Percent

64.6%

64.6%

Marginal clinical significance

6.8%

71.4%

Borderline or Somewhat Deficient

9.1%

80.5%

Mildly Deficient

6.5%

87.0%

Moderately Deficient

8.8%

95.8%

Markedly Deficient or Severe

4.2%

100.0%

Total

100.0%
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Table 4. SSQ Responses Pertaining to the Nature of and Motivations for Self-Reported
Misuse of Prescription Stimulants

Total
Item

Never Rarely Occasionally Frequently Always endorse

1. I have used
prescription
77.6%

9.7%

8.8%

2.9%

1.0%

22.4%

86.4%

7.5%

3.9%

1.6%

0.6%

13.6%

84.4%

7.8%

5.5%

1.9%

0.3%

15.6%

89.3%

5.2%

4.2%

1.0%

0.3%

10.7%

98.1%

1.0%

0.6%

0.0%

0.3%

1.9%

stimulants for nonmedical purposes.
2. I have used
prescription
stimulants at parties.
3. I have used
prescription
stimulants with
alcohol.
4. I have snorted
prescription
stimulants.
5. I have injected
prescription
stimulants.

44

6. I have smoked
prescription

93.8%

2.9%

1.0%

1.9%

0.3%

7.2%

77.9%

5.8%

6.5%

4.9%

4.9%

22.1%b

79.5%

6.8%

5.2%

3.9%

4.5%

20.5%c

88.6%

3.9%

4.2%

1.9%

1.3%

11.4%

92.5%

4.2%

2.3%

0.6%

0.3%

7.5%

75.0%

8.8%

7.5%

3.6%

5.2%

25.0%a

stimulants.
7. I have taken
prescription
stimulants to focus
better in class.b
8. I have taken
prescription
stimulants to perform
better on tests.c
9. I have taken
prescription
stimulants to help me
socialize better.
10. I have taken
prescription
stimulants to help me
lose weight.
11. I have taken
prescription
stimulants to perform
better in my
schoolwork.a
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12. I have taken
prescription
82.5%

7.1%

6.5%

2.3%

1.6%

17.5%

90.3%

2.6%

3.6%

1.9%

1.6%

9.7%

87.3%

6.5%

3.6%

2.6%

0.0%

12.7%

59.1% 20.1%

14.0%

5.2%

1.6%

40.9%

stimulants to feel
more energetic.
13. I have taken
prescription
stimulants to feel
better about myself.
14. I have taken
prescription
stimulants to “get
high”.
15. I have been
offered prescription
stimulants by other
students.
16. I have tried
someone else’s
80.2%

9.1%

6.5%

2.9%

1.3%

19.8%

88.0%

3.9%

5.5%

1.9%

0.6%

12%

prescription stimulant
medication.
17. I have purchased
prescription
stimulants from other
students.
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18. I have sold
prescription stimulant
93.2%

2.9%

2.3%

1.0%

0.6%

6.8%

88.6%

5.8%

2.9%

1.3%

1.3%

11.4%

93.5%

3.6%

1.6%

0.6%

0.6%

6.5%

medication to other
students.
19. I have given
prescription stimulant
medication to other
students.
20. I have been
pressured into letting
someone else have
my prescription
stimulant medication.
a

Denotes most frequently endorsed reason
Second most frequently endorsed reason
c
Third most frequently endorsed reason
b
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Table 5. SSQ Responses Pertaining to the Expressed Attitudes and Perceptions of
Students Regarding Prescription Stimulants

Strongly
Item

Disagree

Strongly
Disagree

Neutral

Agree

Agree

21. Prescription stimulants
are easy to get on this

9.1%

14.3%

32.5%

30.8%

13.3%

14.9%

30.8%

26.9%

21.1%

6.2%

12.3%

23.7%

27.3%

26.3%

10.4%

28.9%

25.6%

20.8%

21.8%

2.9%

51.0%

29.2%

12.7%

3.9%

3.2%

11.4%

19.5%

37.7%

24.7%

6.8%

44.5%

31.2%

20.1%

3.2%

1.0%

31.5%

28.2%

30.8%

7.5%

1.9%

campus.
22. Prescription stimulants
are as easy to get as alcohol.
23. Prescription stimulants
are as easy to get as
marijuana.
24. Using prescription
stimulants occasionally is
harmless.
25. Using prescription
stimulants daily is harmless.
26. Prescription stimulant
use on campus is a problem.
27. Prescription stimulants
are safer than marijuana.
28. Prescription stimulants
are safer than alcohol.
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29. I feel I am
knowledgeable about

14.6%

22.4%

25.6%

22.4%

14.9%

18.8%

23.1%

19.5%

24.7%

14.0%

prescription stimulants.
30. I feel I am
knowledgeable about the
side effects of prescription
stimulants.
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Table 6. SSQ Responses Pertaining to Perceived Misuse of Prescription Stimulants
Among Peers
Item

No

Yes

31. I know students who use prescription
46.1%

53.9%

50.6%

49.4%

52.3%

47.7%

28.6%

71.4%

29.5%

70.5%

37.3%

62.7%

65.6%

34.4%

91.9%

8.1%

81.2%

18.8%

79.9%

20.1%

stimulants at parties.
32. I know students who use prescription
stimulants with alcohol.
33. I know students who use prescription
stimulants with other drugs.
34. I know students who use prescription
stimulants while studying.
35. I know students who use prescription
stimulants during finals week.
36. I know students who use prescription
stimulants during tests.
37. I know students who snort prescription
stimulants.
38. I know students who inject prescription
stimulants.
39. I know students who smoke prescription
stimulants.
40. I hide my prescription stimulant medication so
that no one will take it.
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Table 7. SSQ Addendum Responses pertaining to Frequency and Onset

Total
Item

Never

Rarely Occasionally Frequently Always

endorse

I misused
prescription
stimulants in

99.0
0.6%

0.3%

0.0%

0.0%

1.0%

1.9%

0.0%

1.0%

0.0%

2.9%

6.2%

1.6%

0.3%

0.3%

8.4%

6.5%

1.9%

0.6%

0.3%

9.4%

%

elementary school.
I misused
prescription
97.1
stimulants in
%
middle/ junior high
school.
I misused
prescription
stimulants in high

91.6
%

school.
I have misused
prescription
stimulants prior to

90.6
%

attending college.
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I have misused
prescription

79.5
9.7%

stimulants in

7.5%

%

college.
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2.6%

0.6%

20.5%

Table 8. Contingency table: Executive functioning and prescription stimulant misuse

Have you ever misused a
prescription stimulant
medication?
No
Yes
EF is not abnormal
Marginal clinical
significance
EF Clinical Borderline or Somewhat
Significance deficient

Mildly deficient
Moderately Deficient
Markedly deficient or
severe
Total

53

Total

54.9%

9.7%

64.6%

5.2%

1.6%

6.8%

7.8%

1.3%

9.1%

4.9%

1.6%

6.5%

6.8%

1.9%

8.8%

1.6%

2.6%

4.2%

81.2%

18.8%

100.0%

Table 9. Summary of Multiple Regression Analysis: Onset and Frequency of Misuse,
GPA

Intercept
How frequently do you
misuse prescription
stimulant medication?
I have misused
prescription stimulants
prior to attending
college.
I misused prescription
stimulants in elementary
school.
I misused prescription
stimulants in middle/
junior high school.
I misused prescription
stimulants in high school.
I have misused
prescription stimulants in
college.

Unstandardized Coefficients
B
Std. Error
3.648
.225

Standardized
Coefficients
Beta

t
16.223

Sig.
.000

-.051

.055

-.110

-.932

.352

.071

.124

.072

.572

.568

-.105

.273

-.030

-.384

.701

-.207

.117

-.140

-1.768

.078

-.043

.136

-.039

-.314

.753

.008

.072

.013

.108

.914
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Table 10. Correlations of BDEFs and Self-Reported Misuse of Prescription Stimulants

BDEFs
1
BDEFs
2
BDEFs
3
BDEFs
4
BDEFs
5
BDEFs
Total
SSQ 1

BDEFs
Total

SSQ 1

BDEFs
1

BDEFs
2

BDEFs
3

BDEFs
4

BDEFs
5

1

.682**

.656**

.801**

.543**

.877**

.280**

.682**

1

.645**

.668**

.568**

.864**

.321**

.656**

.645**

1

.745**

.717**

.866**

.513**

.801**

.668**

.745**

1

.608**

.877**

.400**

.543**

.568**

.717**

.608**

1

.778**

.335**

**

**

**

**

**

.877

.280**

.864

.866

.321**

.877

.513**

.400**

.778

.335**

1

.421**

.421**

1

**. Correlation is significant at the 0.01 level (2-tailed).
BDEFs1= Section 1 Score: Self-Management of Time; BDEFs 2= Section 2 Score: Self-Organization/ Problem
Solving; BDEFs 3= Section 3 Score: Self-Restraint; BDEFs 4= Section 4 Score: Self-Motivation; BDEFs 5=
Section 5 Score: Self-Regulation of Emotions; BDEFs Total= Total EF Summary Score; SSQ 1 = Self-Reported
Misuse of Prescription Stimulants; SSQ 2 = Perception of Prevalence of Prescription Stimulant Misuse Among
Peers; SSQ3 = Knowledge of Atypical Stimulant Misuse Among Peers; SSQ 4 = Perception of Safety of
Prescription Stimulant Medication

Table 11. Correlations of BDEFs and Perception of Prevalence of Prescription
Stimulant Misuse Among Peers

SSQ 2

BDEFs 1

BDEFs 2

BDEFs 3

-.019

.111

.152**

BDEF 4
.097

BDEFs 5
.201**

BDEFs
Total
.116*

**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).

Table 12. Correlations of BDEFs and Knowledge of Atypical Stimulant Misuse Among
Peers

SSQ 3

BDEFs 1

BDEFs 2

BDEFs 3

BDEFs 4

BDEFs 5

.168**

.195**

.333**

.249**

.240**

**. Correlation is significant at the 0.01 level (2-tailed).
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BDEFs
Total
.268**

Table 13. Correlations of BDEFs and Perception of Safety of Prescription Stimulant
Medication

SSQ 4

BDEFs 1

BDEFs 2

BDEFs 3

BDEFs 4

BDEFs 5

.201**

.202**

.300**

.257**

.187**

BDEFs
Total
.264**

**. Correlation is significant at the 0.01 level (2-tailed).

Table 14. Correlations of BDEFs and SSQ Total Score
BDEFs 1

BDEFs 2

BDEFs 3

BDEFs 4

BDEFs 5

.240**

.320**

.435**

.350**

.308**

SSQ
Total

**. Correlation is significant at the 0.01 level (2-tailed).
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BDEFs
Total
.379**

APPENDICES
Appendix A
Informed Consent
The University of Rhode Island
Interdisciplinary Neuroscience Graduate Program
Prescription stimulant misuse: the relationship between executive functioning and
academic outcomes
PLEASE PRINT AND KEEP THIS FORM FOR YOURSELF
Dear Participant:
You have been asked to take part in a research project described below. The researcher
will explain the project to you in detail. If you have any questions, please feel free to
contact the student investigator, Bailey Munro, at (401)-580-5959 or
bailey_munro@uri.edu, or the faculty sponsor, Dr. Lisa Weyandt, at (401)-874-2194
or lisaweyandt@uri.edu.
The purpose of this study is to examine the misuse of prescription stimulant
medications and its relation to executive functioning and academic outcomes.
Responses to survey items are completely anonymous: there will be no identifying
information linking you to your responses or to any particular organization. The
survey will take about 15 minutes to complete. Data will be encrypted and stored
through the website GoogleForms, and only the principal investigator, Dr. Lisa
Weyandt, and student investigator, Bailey Munro, will have access to the data through
the use of a password.
YOU MUST BE AT LEAST 18 YEARS OLD to participate in this research project.
If you are not, please discontinue the survey at this time.
If you decide to participate in this study, it will involve completing some
questionnaires pertaining to your perceptions about prescription stimulant medication,
your executive functioning, and your academic functioning.
The possible risks of the study are minimal, although you may feel some
embarrassment answering questions of a personal nature. Please respond honestly, and
remember that your responses are anonymous.
Although there are no direct benefits of the study, your answers will help to increase
knowledge about the complexities of non-prescription stimulant use on college
campuses.
Your participation in this study is anonymous. This means that your answers to all
questions are private. No one else can know that you participated in this study, and no
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one can find out what your answers were to any items. Scientific reports will be based
on aggregated group data, and will not identify you or any individual in this project.
The decision to participate in this research project is up to you. You do not have to
participate, and you can decline to answer the questionnaires. If you decide to take
part in the study, you may quit at any time. Whatever you decide will in no way
penalize you or your status as a student. Participation in this study is not expected to
be harmful or injurious to you.
If you have any additional questions or concerns about this study, you may contact the
student investigator, Bailey Munro, at (401)-580-5959 or bailey_munro@my.uri.edu,
or her faculty sponsor, Dr. Lisa Weyandt, at (401)-874-2194, or the University of
Rhode Island’s Vice Provost for Graduate Studies, Research and Outreach, 70 Lower
College Road, Suite 2, URI, Kingston, RI; (401)-874-4328.
By clicking this box, you are indicating that:
You are at least 18 years old.
You have read the consent form and your questions have been answered to your
satisfaction. Your completion of the surveys implies your consent to participate in this
study.
If these questions are upsetting and you want to talk please use the phone numbers below:
The University of Rhode Island Counseling Center
www.uri.edu/coun
(401) 874-2288
Roosevelt Hall, 2nd floor
Florida Atlantic University Counseling and Psychological Services
http://www.fau.edu/counseling/
(561) 297-3540
Student Services Building (SSB #8), Room 229
University of California, Santa Barbara Counseling Center
http://caps.sa.ucsb.edu
(805) 893-4411
Building 599
University of California, Irvine Counseling Center
http://www.counseling.uci.edu
(949) 824-6457
203 Student Services 1
5500 Campanile Dr.
Central Washington University Counseling Center
http://www.cwu.edu/medical-counseling/
(509) 963-1391
400 E. University Way
The University of Michigan Counseling and Psychological Services
http://www.umich.edu/~caps/
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(734) 764-8312
Michigan Union, Room 3100
530 S. State Street
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Appendix B
Demographic Questionnaire
1. Current age (in years): ___________
2. Sex:
Male
Female
Other: __________
3. Race/Ethnicity (please circle one):
White
Black or African American
Asian
American Indian or Alaska Native
Native Hawaiian or Other Pacific Island
Other: _________
4a. What university do you currently attend?
University of Rhode Island
Central Washington University
University of Michigan
Florida Atlantic University
University of California, Irvine
University of California, Santa Barbara
4b. Class year (please circle one):
Freshman
Sophomore
Junior

Senior

Other

5. Cumulative Grade Point Average (fill in a number between 0.0 and 4.0):
__________
6. How many class session are in your schedule each week? (For example: A class that meets
Monday, Wednesday and Friday has 3 class session each week): _______________
7. How many hours per week on average do you spend studying? ________________
8. How many classes do you typically skip per week? ________________
9. What is your college major(s) (choose interest area)?
Business Administration
Communication and Media
Education
Engineering
Environmental Studies
Healthcare and Clinical Sciences
Humanities and Social Sciences
Languages and Literature
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Mathematics and Computer Science
Natural and Physical Science
Political and Global Studies
Visual and Performing Arts and Design
Undecided/ Undeclared
10. Are you currently a member of sorority or fraternity?
Yes

No

11. Have you ever been diagnosed with Attention-Deficit-Hyperactivity Disorder
(ADHD)?
Yes

No

11a. If you answered “yes” to Question 11, with what subtype/presentation of ADHD are
you diagnosed?
Hyperactive/Impulsive Type
Inattentive Type
Combined Type
Do not know
Never diagnosed with ADHD
11b. If you answered “yes” to Question 11, at what age were you first diagnosed?
_______
12. Are you currently taking stimulant medications including methylphenidate
(Ritalin, Concerta, Metadate) and amphetamine (Adderall, Dexedrine, Desoxyn) that
have been prescribed to you by a doctor?
Yes

No

13. Please endorse any of the following psychological conditions that you have previously
been or are currently diagnosed with:
Anxiety
Depression
Bi-polar disorder
Eating disorder
Specific learning disability
14. Are you currently registered with the Disabilities Support Services office at your
university?
Yes

No

15. What type of high school did you attend?
Public
Private
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Other: ______
16. Do you intend to pursue graduate school (medical, dental, law, masters-degree, PhD)
upon completion of your bachelors degree?
Yes

No

17. Number of hours typically spent exercising per week: ____________
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Appendix C
Stimulant Survey Questionnaire (SSQ)
Please answer the following questions about your college experience truthfully.
Stimulants refer to prescription medications including methylphenidate (Ritalin, Concerta, Metadate)
and amphetamine (Adderall, Dexedrine, Desoxyn).
Please circle the number that best describes your agreement with each statement.
These questions are rated on a Likert scale:
1. I have used prescription stimulants for non-medical purposes.
2.
3.
4.
5.

I have used prescription stimulants at parties.
I have used prescription stimulants with alcohol.
I have snorted prescription stimulants.
I have injected prescription stimulants.

Never
1

Rarely Occasionally Frequently Always
2
3
4
5

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

5
5
5
5

6. I have smoked prescription stimulants.
7. I have taken prescription stimulants to focus better in class.

1
1

2
2

3
3

4
4

5
5

8. I have taken prescription stimulants to perform better on tests.
9. I have taken prescription stimulants to help me socialize better.

1
1

2
2

3
3

4
4

5
5

10. I have taken prescription stimulants to help me lose weight.

1

2

3

4

5

11. I have taken prescription stimulants to perform
better in my school work.
12. I have taken prescription stimulants to feel more energetic.
13. I have taken prescription stimulants to feel better about myself.
14. I have taken prescription stimulants to “get high”.
15. I have been offered prescription stimulants by other students.
16. I have tried someone else’s prescription stimulant medication.
17. I have purchased prescription stimulants from other students.
18. I have sold prescription stimulant medication to other students.
19. I have given prescription stimulant medication to other students.
20. I have been pressured into letting someone else
have my prescription stimulant medication.

1

2

3

4

5

1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5
5

Please answer the following questions about your college experience truthfully.
Stimulants refer to prescription medications including methylphenidate (Ritalin, Concerta, Metadate)
and amphetamine (Adderall, Dexedrine, Desoxyn).
Please circle the number that best describes your agreement with each statement.
Strongly
Disagree
1
1
1
1
1
1
1
1
1
1

These questions are rated on a Likert scale:
21. Prescription stimulants are easy to get on this campus.
22. Prescription stimulants are as easy to get as alcohol.
23. Prescription stimulants are as easy to get as marijuana.
24. Using prescription stimulants occasionally is harmless.
25. Using prescription stimulants daily is harmless.
26. Prescription stimulant use on campus is a problem.
27. Prescription stimulants are safer than marijuana.
28. Prescription stimulants are safer than alcohol.
29. I feel I am knowledgeable about prescription stimulants.
30. I feel I am knowledgeable about the side effects
of prescription stimulants.

Disagree
2
2
2
2
2
2
2
2
2
2

Neutral
3
3
3
3
3
3
3
3
3
3

Agree
4
4
4
4
4
4
4
4
4
4

YES
YES
YES
YES
YES

NO
NO
NO
NO
NO

Please Circle Yes or No to the following questions:
31. I know students who use prescription stimulants at parties.
32. I know students who use prescription stimulants with alcohol.
33. I know students who use prescription stimulants with other drugs.
34. I know students who use prescription stimulants while studying.
35. I know students who use prescription stimulants during finals week.
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Strongly
Agree
5
5
5
5
5
5
5
5
5
5

36. I know students who use prescription stimulants during tests.
37. I know students who snort prescription stimulants.
38. I know students who inject prescription stimulants.
39. I know students who smoke prescription stimulants.
40. I hide my prescription stimulant medication so that no one will take it.
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YES
YES
YES
YES
YES

NO
NO
NO
NO
NO

Appendix D
SSQ Addendum Questions
1. Are you currently prescribed a stimulant medication to treat ADHD?

Yes

No

Yes

No

If Yes, what medication __________________
2. Have you ever been prescribed a stimulant medication?

If Yes, when ______________________ (elementary, middle/junior high school, high school,
college)
3. Have you ever misused a prescription stimulant medication?

Yes

No

If yes, when was the first time ______________________(elementary, middle/junior high
school, high school, college)
4. Where do you typically obtain stimulant medications?
Doctor

Friends who share

Friends who sell

I steal them

Family

the Internet

5. How frequently do you misuse prescription stimulant medication?
Never Once a year Twice a year Once a month

Once a week More than once a week

Never

Rarely Occasionally Frequently Always

6. I have misused prescription stimulants prior to attending college.

1

2

3

4

5

7. I misused prescription stimulants in elementary school.

1

2

3

4

5

8. I misused prescription stimulants in middle/ junior high school.

1

2

3

4

5

9. I misused prescription stimulants in high school.

1

2

3

4

5

10. I have misused prescription stimulants in college.

1

2

3

4

5
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Appendix E
Additional Information on the SSQ
Factor 1:
Factor 2:
Factor 3:
Factor 4:

Self-reported prescription stimulant use
Perception of prevalence of prescription use among peers
Knowledge of atypical stimulant use among peers
Perception of safety of stimulants

Cronbach’s alpha coefficient of .849 for all 40 items of the SSQ. The internal consistency of the four
factors was as follows: Factor 1 Cronbach’s alpha coefficient = .923; Factor 2 Cronbach’s alpha
coefficient = .434; Factor 3 Cronbach’s alpha coefficient = .613; and Factor 4 Cronbach’s alpha
coefficient = .608.

Factor Structure for the Stimulant Survey Questionnaire
Factor
1
2

Item
I have used prescription stimulants for non-medical purposes.
I have used prescription stimulants at parties.
I have used prescription stimulants with alcohol.
I have snorted prescription stimulants.
I have injected prescription stimulants.
I have smoked prescription stimulants.
I have taken prescription stimulants to focus better in class.
I have taken prescription stimulants to perform better on tests.
I have taken prescription stimulants to help me socialize better.
I have taken prescription stimulants to help me lose weight.
I have taken prescription stimulants to perform better in school work.
I have taken prescription stimulants to feel energetic.
I have taken prescription stimulants to feel better about myself
I have taken prescription stimulants to “get high.”
I have been offered prescription stimulants by other students.
I have tried someone else’s prescription stimulants.
I have purchased prescription stimulants from other students.
I have sold prescription stimulants to other students.
I have given prescription stimulants to other students.
I have been pressured into letting someone else have my
prescription stimulant medication.
Prescription stimulants are easy to get on this campus.
Prescription stimulants are as easy to get as alcohol.
Prescription stimulants are as easy to get as marijuana.
Using prescription stimulants occasionally is harmless.
Using prescription stimulants daily is harmless.
Prescription stimulant use on campus is a problem.
Prescription stimulants are safer than marijuana.
Prescription stimulants are safer than alcohol.
I feel I am knowledgeable about prescription stimulants.
I feel I am knowledgeable about the side effects of
prescription stimulants.
I know students who use prescription stimulants at parties.
I know students who use prescription stimulants with alcohol.
I know students who use prescription stimulants with other drugs.
I know students who use prescription stimulants while studying.
I know students who use prescription stimulants during finals week.
I know students who use prescription stimulants during tests.
I know students who snort prescription stimulants.
I know students who inject prescription stimulants.
I know students who smoke prescription stimulants.
I hide my prescription stimulant medication so that no one will take it.
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.768
.737
.736
.673

3

4___

-.302
-.632
-.616

.834
.854
.520
.528
.861
.825
.567
.501
.428
.758
.746
.556
.581

-.395

-.477
-.419

-.622
-.533
-.569
.405

.551
.341
-.362
.770
.721
-.457

.405
.341

-.507
.754
.723
.690
.777
.780
.763
.517
.356

.685
.600

Appendix F
2015-2016 Common Data Set
Reported Demographic Information
University of Rhode Island
Gender
Total Undergraduate Students

13,641

Male Student Percentage

46%

Female Student Percentage

54%

Ethnicity
Hispanic/Latino

9.45%

Black or African American

5.21%

White or Caucasian

69.75%

American Indian or Alaska Native

0.23%

Asian

3.22%

Native Hawaiian or other Pacific Islander

0.03%

Two or more races

2.77%

Unknown

7.29%

Florida Atlantic University
Gender
Total Undergraduate Students

25,209

Male Student Percentage

44%

Female Student Percentage

56%

Ethnicity
Hispanic/Latino

25.2%
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Black or African American

19.16%

White or Caucasian

44.62%

American Indian or Alaska Native

0.19%

Asian

4.2%

Native Hawaiian or other Pacific Islander

0.12%

Two or more races

3.19%

Unknown

1.46%

University of Michigan
Gender
Total Undergraduate Students

28,312

Male Student Percentage

51%

Female Student Percentage

49%

Ethnicity
Hispanic/Latino

4.59%

Black or African American

4.29%

White or Caucasian

61.35%

American Indian or Alaska Native

0.19%

Asian

12.7%

Native Hawaiian or other Pacific Islander

0.04%

Two or more races

3.42%

Unknown

6.5%

Central Washington University
Gender
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Total Undergraduate Students

10,982

Male Student Percentage

49%

Female Student Percentage

51%

Ethnicity
Hispanic/Latino

13.75%

Black or African American

3.66%

White or Caucasian

58.94%

American Indian or Alaska Native

0.72%

Asian

4.05%

Native Hawaiian or other Pacific Islander

0.64%

Two or more races

6.66%

Unknown

8.54%

University of California Irvine
Gender
Total Undergraduate Students

25,256

Male Student Percentage

46%

Female Student Percentage

54%

Ethnicity
Hispanic/Latino

24.87%

Black or African American

1.65%

White or Caucasian

12.28%

American Indian or Alaska Native

0.04%

Asian

37.23%

Native Hawaiian or other Pacific Islander

0.1%
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Two or more races

3.79%

Unknown

4.32%

University of California Santa Barbara
Gender
Total Undergraduate Students

20,607

Male Student Percentage

47%

Female Student Percentage

53%

Ethnicity
Hispanic/Latino

25.92%

Black or African American

2.2%

White or Caucasian

35.36%

American Indian or Alaska Native

0.14%

Asian

19.48%

Native Hawaiian or other Pacific Islander

0.13%

Two or more races

8.4%

Unknown

1.31%
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